Idit Dotan

466 total citations
34 papers, 230 citations indexed

About

Idit Dotan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Idit Dotan has authored 34 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in Idit Dotan's work include Inflammatory Bowel Disease (7 papers), Pituitary Gland Disorders and Treatments (6 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Idit Dotan is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Pituitary Gland Disorders and Treatments (6 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Idit Dotan collaborates with scholars based in Israel, United States and Canada. Idit Dotan's co-authors include Amit Akirov, Ilan Shimon, Talia Diker‐Cohen, Dror Dicker, Nursel Çalık Başaran, Tzippy Shochat, Alexander Gorshtein, Hiba Masri‐Iraqi, Mark Trifiro and Philip J. R. Roche and has published in prestigious journals such as PLoS ONE, International Journal of Obesity and Transplantation.

In The Last Decade

Idit Dotan

28 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Idit Dotan Israel 9 135 88 35 28 28 34 230
Gaye Siliman Canada 8 110 0.8× 94 1.1× 47 1.3× 38 1.4× 13 0.5× 10 307
Juan Manuel Millán-Alanís Mexico 8 142 1.1× 122 1.4× 15 0.4× 59 2.1× 35 1.3× 23 334
Hans Zmierczak Belgium 9 97 0.7× 47 0.5× 61 1.7× 101 3.6× 28 1.0× 11 335
Razman Arabzadeh Bahri Iran 8 47 0.3× 35 0.4× 30 0.9× 16 0.6× 63 2.3× 31 209
L. Monge Italy 9 122 0.9× 108 1.2× 20 0.6× 16 0.6× 23 0.8× 19 259
О. Б. Безлепкина Russia 9 240 1.8× 55 0.6× 41 1.2× 76 2.7× 17 0.6× 79 327
Valentina Raffaelli Italy 10 312 2.3× 143 1.6× 10 0.3× 15 0.5× 26 0.9× 14 381
Shishi Xu China 9 76 0.6× 84 1.0× 68 1.9× 56 2.0× 12 0.4× 24 221
Anni Wong United States 9 112 0.8× 133 1.5× 15 0.4× 17 0.6× 39 1.4× 22 246
Soma Saha India 12 83 0.6× 174 2.0× 33 0.9× 45 1.6× 26 0.9× 32 345

Countries citing papers authored by Idit Dotan

Since Specialization
Citations

This map shows the geographic impact of Idit Dotan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Idit Dotan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Idit Dotan more than expected).

Fields of papers citing papers by Idit Dotan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Idit Dotan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Idit Dotan. The network helps show where Idit Dotan may publish in the future.

Co-authorship network of co-authors of Idit Dotan

This figure shows the co-authorship network connecting the top 25 collaborators of Idit Dotan. A scholar is included among the top collaborators of Idit Dotan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Idit Dotan. Idit Dotan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diker‐Cohen, Talia, I. Bergman, Tanya Babich, et al.. (2025). Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus. Diabetes & Metabolism. 51(3). 101627–101627. 3 indexed citations
2.
Shimon, Ilan, Tzippy Shochat, Idit Dotan, et al.. (2025). Mortality in patients with dopamine agonist-treated hyperprolactinemia: a large matched-cohort study. Pituitary. 28(6). 116–116.
3.
Stern, Julia, Ilan Shimon, Idit Dotan, et al.. (2025). Weight gain reversibility and BMI following treatment for Cushing’s syndrome: long-term outcomes and potential predictors. Pituitary. 28(4). 78–78. 1 indexed citations
4.
Diker‐Cohen, Talia, et al.. (2025). Glucagon-like peptide 1 receptor agonists and renal outcomes in kidney transplant recipients with diabetes mellitus. Diabetes & Metabolism. 51(3). 101624–101624. 2 indexed citations
5.
Dotan, Idit, et al.. (2025). Real-World Evidence for Metformin Use in Solid Organ Transplant Recipients Living With Diabetes. Endocrine Practice. 32(3). 360–368.
6.
Pfeffer‐Gik, Tamar, Lihi Godny, Shimon Cohen, et al.. (2025). P0955 Calcium supplementation, but not the Mediterranean diet, significantly reduced bone resorption metabolite in patients with inflammatory bowel disease (IBD): A randomized controlled trial. Journal of Crohn s and Colitis. 19(Supplement_1). i1782–i1782.
7.
Shimon, Ilan, et al.. (2024). Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis. Pituitary. 28(1). 10–10. 2 indexed citations
8.
Başaran, Nursel Çalık, Idit Dotan, & Dror Dicker. (2024). Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels. International Journal of Obesity. 49(3). 412–417. 31 indexed citations
9.
Dotan, Idit, Tzippy Shochat, Talia Diker‐Cohen, Amit Akirov, & Alexander Gorshtein. (2024). Glycemic Management Among Adults With Type 1 Diabetes During Passover: A Pre–Post Single-center Study. Canadian Journal of Diabetes. 48(5). 299–304.
10.
Ben‐Horin, Shomron, Nir Salomon, N. Viazis, et al.. (2023). P560 Curcumin-QingDai combination for patients with active ulcerative colitis: A randomized double-blinded placebo-controlled trial. Journal of Crohn s and Colitis. 17(Supplement_1). i691–i691. 2 indexed citations
11.
Focht, Gili, Ohad Atia, Shira Greenfeld, et al.. (2023). OP12 Does early initiation of biologics change the natural history of IBD? a nationwide study from the epi-IIRN. Journal of Crohn s and Colitis. 17(Supplement_1). i17–i18. 2 indexed citations
12.
Masri‐Iraqi, Hiba, Idit Dotan, Talia Diker‐Cohen, et al.. (2023). The Association Between Hypothyroidism Treatment and Mortality in Patients Hospitalized in Surgical Wards. Endocrine Research. 48(2-3). 68–76.
13.
Atia, Ohad, Idan Goren, Yiska Loewenberg Weisband, et al.. (2023). P467 5-ASA is not superior to no-maintenance in patients with newly diagnosed Crohn’s disease - a nationwide cohort from the epi-IIRN. Journal of Crohn s and Colitis. 17(Supplement_1). i596–i596. 1 indexed citations
14.
Akirov, Amit, Ilan Shimon, Maria Fleseriu, et al.. (2022). Clinical Study and Systematic Review of Pituitary Microadenomas vs. Macroadenomas in Cushing’s Disease: Does Size Matter?. Journal of Clinical Medicine. 11(6). 1558–1558. 8 indexed citations
15.
Dotan, Idit, Tzippy Shochat, Ilan Shimon, & Amit Akirov. (2021). The Association Between BMI and Mortality in Surgical Patients. World Journal of Surgery. 45(5). 1390–1399. 10 indexed citations
16.
Akirov, Amit, et al.. (2021). Long-term safety and efficacy of long-acting pasireotide in acromegaly. Endocrine. 74(2). 396–403. 21 indexed citations
17.
Akirov, Amit, Hiba Masri‐Iraqi, Idit Dotan, & Ilan Shimon. (2021). The Biochemical Diagnosis of Acromegaly. Journal of Clinical Medicine. 10(5). 1147–1147. 24 indexed citations
18.
Akirov, Amit, Tzippy Shochat, Idit Dotan, et al.. (2019). Glycemic variability and mortality in patients hospitalized in general surgery wards. Surgery. 166(2). 184–192. 25 indexed citations
19.
Yanai, Henit, et al.. (2012). P202 Primary sclerosing cholangitis: A case series and natural history. Journal of Crohn s and Colitis. 6. S90–S90.
20.
Averbuch, Mordechai, Daniel Ayalon, Nachman Eckstein, et al.. (1998). Hormone replacement and simvastatin in the therapy of hypercholesterolemic postmenopausal women.. PubMed. 29(5-6). 343–50. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaye Siliman Breakdown of academic impact, for papers by Juan Manuel Millán-Alanís Breakdown of academic impact, for papers by Hans Zmierczak Breakdown of academic impact, for papers by Razman Arabzadeh Bahri Breakdown of academic impact, for papers by L. Monge Breakdown of academic impact, for papers by О. Б. Безлепкина Breakdown of academic impact, for papers by Valentina Raffaelli Breakdown of academic impact, for papers by Shishi Xu Breakdown of academic impact, for papers by Anni Wong Breakdown of academic impact, for papers by Soma Saha
Rankless by CCL
2026